43.97 USD
↘ 0.32 (0.72%)LIVE (AS OF 12:16 PM EDT)
Shares of Franklin Genomic Advancements ETF (HELX) are trading at $43.97. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment.
Technical & fundamental data as of Sep 24, 2026.